Decreased white matter integrity in late-myelinating fiber pathways in Alzheimer's disease supports retrogenesis

N H Stricker1, B C Schweinsburg, L Delano-Wood

  • 1New Mexico VA Healthcare System, USA.

Neuroimage
|December 23, 2008
PubMed

Insights

Alzheimer's disease (AD) causes white matter (WM) degeneration in late-myelinating pathways, supporting the retrogenesis model. Early-myelinating pathways showed no significant changes in AD patients compared to healthy adults.

Area of Science:

  • Neuroscience
  • Neurology
  • Radiology

Background:

  • Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive cognitive decline.
  • The retrogenesis model proposes that white matter (WM) degeneration in AD mirrors the reverse of normal myelogenesis.
  • Understanding WM changes is crucial for early AD detection and intervention.

Purpose of the Study:

  • To test the retrogenesis model of AD using diffusion tensor imaging (DTI).
  • To investigate microstructural integrity differences in early- and late-myelinating WM pathways between AD patients and healthy adults.

Main Methods:

  • Employed diffusion tensor imaging (DTI) and tract-based spatial statistics (TBSS) for whole-brain analysis.
  • Utilized region of interest (ROI) analysis targeting specific early- (posterior limb of internal capsule, cerebral peduncles) and late-myelinating (inferior longitudinal fasciculus [ILF], superior longitudinal fasciculus [SLF]) fiber pathways.
  • Compared 16 AD patients with 14 demographically-matched healthy older adults.

Main Results:

  • Significantly lower fractional anisotropy (FA) was observed in late-myelinating WM pathways in AD patients compared to controls.
  • No significant differences in FA were found in early-myelinating pathways between the groups.
  • Increased radial diffusion in AD patients suggested myelin integrity loss, particularly in the ILF.

Conclusions:

  • Findings support the retrogenesis model, indicating that AD preferentially affects late-myelinating WM pathways.
  • Myelin degeneration in late-myelinating tracts is a key feature of AD's WM pathology.
  • Wallerian degeneration secondary to cortical atrophy may also contribute to WM changes in AD.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Neurogenesis and Regeneration of Nervous Tissue01:15

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...